BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 10690537)

  • 1. Topological analysis of p21WAF1/CIP1 expression in esophageal squamous dysplasia.
    Shirakawa Y; Naomoto Y; Kimura M; Kawashima R; Yamatsuji T; Tamaki T; Hamada M; Haisa M; Tanaka N
    Clin Cancer Res; 2000 Feb; 6(2):541-50. PubMed ID: 10690537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix.
    Werness BA; Wang HQ; Chance J; Goldstein DJ
    Mod Pathol; 1997 Jun; 10(6):578-84. PubMed ID: 9195575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological studies of esophageal carcinoma in achalasia: analyses of carcinogenesis using histological and immunohistochemical procedures.
    Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Oshiba G; Kise Y; Kajiwara H; Tsuchida T; Tanaka M; Tajima T; Makuuchi H
    Anticancer Res; 2000; 20(5C):3717-22. PubMed ID: 11268444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients.
    Lam KY; Law S; Tin L; Tung PH; Wong J
    Am J Gastroenterol; 1999 Aug; 94(8):2060-8. PubMed ID: 10445528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.
    Itakura Y; Sasano F; Date F; Kato K; Sekine H; Mori S; Nagura H
    Anticancer Res; 1996; 16(1):201-8. PubMed ID: 8615609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma.
    Hayashi H; Miyamoto H; Ito T; Kameda Y; Nakamura N; Kubota Y; Kitamura H
    Am J Pathol; 1997 Aug; 151(2):461-70. PubMed ID: 9250158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
    Chatelain D; Fléjou JF
    Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
    Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
    Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of MAL expression in precancerous lesions of the esophagus.
    Mimori K; Nishida K; Nakamura Y; Ieta K; Yoshikawa Y; Sasaki A; Ishii H; Alonso MA; Mori M
    Ann Surg Oncol; 2007 May; 14(5):1670-7. PubMed ID: 17151798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
    Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
    Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology of early esophageal carcinoma and squamous epithelial dysplasia.
    Kuwano H; Baba K; Ikebe M; Adachi Y; Toh Y; Sugimachi K
    Hepatogastroenterology; 1993 Jun; 40(3):222-5. PubMed ID: 8325586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase II alpha expression in esophageal squamous cell carcinoma.
    Ohashi Y; Sasano H; Yamaki H; Shizawa S; Kikuchi A; Shineha R; Akaishi T; Satomi S; Nagura H
    Anticancer Res; 1999; 19(3A):1873-80. PubMed ID: 10470130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
    Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T
    Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma.
    Natsugoe S; Nakashima S; Matsumoto M; Xiangming C; Okumura H; Kijima F; Ishigami S; Takebayashi Y; Baba M; Takao S; Aikou T
    Clin Cancer Res; 1999 Sep; 5(9):2445-9. PubMed ID: 10499617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclin-dependent kinases inhibitors p21(WAF1) and p27(KIP1) in benign, premalignant and malignant laryngeal lesions. correlation with cell cycle regulatory proteins.
    Peschos D; Tsanou E; Stefanou D; Damala C; Vougiouklakis T; Mitselou A; Agnantis NJ
    In Vivo; 2004; 18(6):719-24. PubMed ID: 15646812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities.
    Sarbia M; Stahl M; zur Hausen A; Zimmermann K; Wang L; Fink U; Heep H; Dutkowski P; Willers R; Müller W; Seeber S; Gabbert HE
    Clin Cancer Res; 1998 Nov; 4(11):2615-23. PubMed ID: 9829724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.